Edition:
United Kingdom

TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

6.26USD
8 Dec 2017
Change (% chg)

-- (--)
Prev Close
$6.26
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
505,905
52-wk High
$8.29
52-wk Low
$3.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 December 11 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 3 4 4 4
(3) HOLD 1 1 1 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.62 1.67 1.67 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 6 4.69 5.49 4.00 --
Quarter Ending Mar-18 2 4.29 4.58 4.00 --
Year Ending Dec-17 8 17.81 20.00 16.70 52.19
Year Ending Dec-18 8 38.78 42.01 34.55 185.38
Earnings (per share)
Quarter Ending Dec-17 7 -0.09 -0.08 -0.13 -0.08
Quarter Ending Mar-18 2 -0.13 -0.11 -0.15 --
Year Ending Dec-17 7 -0.37 -0.35 -0.41 -0.41
Year Ending Dec-18 8 -0.43 -0.25 -0.64 0.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 5.22 4.42 0.80 15.35
Quarter Ending Jun-17 4.91 4.25 0.66 13.46
Quarter Ending Mar-17 5.23 3.98 1.25 23.81
Quarter Ending Dec-16 5.91 4.49 1.42 24.07
Quarter Ending Sep-16 5.76 5.54 0.23 3.95
Earnings (per share)
Quarter Ending Sep-17 -0.11 -0.07 0.04 -35.66
Quarter Ending Jun-17 -0.11 -0.10 0.01 -7.92
Quarter Ending Mar-17 -0.11 -0.11 0.00 -1.52
Quarter Ending Dec-16 -0.12 -0.12 0.00 -3.46
Quarter Ending Sep-16 -0.11 -0.13 0.02 -15.56

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4.69 4.69 4.69 4.89 --
Quarter Ending Mar-18 4.29 4.29 4.29 17.37 --
Year Ending Dec-17 17.81 17.81 17.81 18.94 52.19
Year Ending Dec-18 38.78 38.78 55.05 65.11 185.38
Earnings (per share)
Quarter Ending Dec-17 -0.09 -0.09 -0.10 -0.11 -0.08
Quarter Ending Mar-18 -0.13 -0.13 -0.13 -0.10 --
Year Ending Dec-17 -0.37 -0.37 -0.38 -0.45 -0.41
Year Ending Dec-18 -0.43 -0.43 -0.37 -0.33 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 2
Earnings
Quarter Ending Dec-17 0 0 1 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 1 0
Year Ending Dec-18 0 0 0 2